Lv1
66 积分 2022-03-30 加入
Biliary tract cancer
1个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
1个月前
已完结
Physicians’ perceptions of HCC conversion/downstaging therapy: a nationwide survey among tertiary hospital physicians in China
1个月前
已完结
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
1个月前
已完结
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer
1个月前
已完结
From bench to bedside: the evolving role of iodine in thyroid cancer management
1个月前
已完结
Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
1个月前
已完结
Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer
1个月前
已完结
BRAF(V600E)基因突变甲状腺癌诊疗专家共识（2026版）
1个月前
已完结
Hallmarks of liver cancer: Therapeutic implications
2个月前
已完结
皖公网安备34019202002308
